Insiders · Profile

Shirvan Mitchell

CSO and CDO at Silexion Therapeutics. Filing since 26 Mar 2026. CIK 0001727789

Company

Date

Role

Action

Shares

Amount

Of holding

SLXN Silexion Therapeutics Corp

26 Mar 2026

CSO and CDO

Sold at will

22,818

$31.03K

45.0%

1 decision on file.